Tammy T Hshieh1, Andrew B Petrone1, J Michael Gaziano1, Luc Djoussé1. 1. From the Divisions of Aging (TTH, ABP, JMG, and LD) and Preventive Medicine (JMG), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; the Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, MA (TTH); and the Massachusetts Veterans Epidemiology and Research Information Center (MAVERIC), Geriatric Research (GRECC) and VA Boston Healthcare System, Boston, MA (JMG and LD).
Abstract
BACKGROUND: Previous studies have suggested that nut consumption is associated with beneficial cardiovascular outcomes. However, limited data are available on the association between nut intake and all-cause mortality. OBJECTIVE: Our aim was to test the hypothesis that nut consumption is inversely associated with the risk of all-cause mortality. DESIGN: In this prospective cohort study in 20,742 male physicians, we assessed nut intake between 1999 and 2002 via a food-frequency questionnaire and ascertained deaths through an endpoint committee. We used Cox regression to estimate multivariable-adjusted HRs for death according to nut consumption. In secondary analyses, we evaluated associations of nut consumption with cause-specific mortality. RESULTS: During a mean follow-up of 9.6 y, there were 2732 deaths. The mean (±SD) age at baseline was 66.6 ± 9.3 y. Median nut consumption was 1 serving/wk. Multivariable-adjusted HRs (95% CIs) were 1.0 (reference), 0.92 (0.83, 1.01), 0.85 (0.76, 0.96), 0.86 (0.75, 0.98), and 0.74 (0.63, 0.87) for nut consumption of never or <1 serving/mo, 1-3 servings/mo, 1 serving/wk, 2-4 servings/wk, and ≥5 servings/wk, respectively (P-linear trend < 0.0001), after adjustment for age, body mass index, alcohol use, smoking, exercise, prevalent diabetes and hypertension, and intakes of energy, saturated fat, fruit and vegetables, and red meat. In a secondary analysis, results were consistent for cardiovascular disease mortality but only suggestive and non-statistically significant for coronary artery disease and cancer mortality. CONCLUSION: Our data are consistent with an inverse association between nut consumption and the risk of all-cause and cardiovascular disease mortality in US male physicians.
BACKGROUND: Previous studies have suggested that nut consumption is associated with beneficial cardiovascular outcomes. However, limited data are available on the association between nut intake and all-cause mortality. OBJECTIVE: Our aim was to test the hypothesis that nut consumption is inversely associated with the risk of all-cause mortality. DESIGN: In this prospective cohort study in 20,742 male physicians, we assessed nut intake between 1999 and 2002 via a food-frequency questionnaire and ascertained deaths through an endpoint committee. We used Cox regression to estimate multivariable-adjusted HRs for death according to nut consumption. In secondary analyses, we evaluated associations of nut consumption with cause-specific mortality. RESULTS: During a mean follow-up of 9.6 y, there were 2732 deaths. The mean (±SD) age at baseline was 66.6 ± 9.3 y. Median nut consumption was 1 serving/wk. Multivariable-adjusted HRs (95% CIs) were 1.0 (reference), 0.92 (0.83, 1.01), 0.85 (0.76, 0.96), 0.86 (0.75, 0.98), and 0.74 (0.63, 0.87) for nut consumption of never or <1 serving/mo, 1-3 servings/mo, 1 serving/wk, 2-4 servings/wk, and ≥5 servings/wk, respectively (P-linear trend < 0.0001), after adjustment for age, body mass index, alcohol use, smoking, exercise, prevalent diabetes and hypertension, and intakes of energy, saturated fat, fruit and vegetables, and red meat. In a secondary analysis, results were consistent for cardiovascular disease mortality but only suggestive and non-statistically significant for coronary artery disease and cancer mortality. CONCLUSION: Our data are consistent with an inverse association between nut consumption and the risk of all-cause and cardiovascular disease mortality in US male physicians.
Authors: Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González Journal: N Engl J Med Date: 2013-02-25 Impact factor: 91.245
Authors: Stephen C Cunnane; Julie A Schneider; Christine Tangney; Jennifer Tremblay-Mercier; Mélanie Fortier; David A Bennett; Martha Clare Morris Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Marta Guasch-Ferré; Mònica Bulló; Nancy Babio; Miguel A Martínez-González; Ramon Estruch; María-Isabel Covas; Julia Wärnberg; Fernando Arós; José Lapetra; Lluís Serra-Majem; Josep Basora; Jordi Salas-Salvadó Journal: J Gerontol A Biol Sci Med Sci Date: 2013-04-17 Impact factor: 6.053
Authors: Marta Guasch-Ferré; Mònica Bulló; Miguel Ángel Martínez-González; Emilio Ros; Dolores Corella; Ramon Estruch; Montserrat Fitó; Fernando Arós; Julia Wärnberg; Miquel Fiol; José Lapetra; Ernest Vinyoles; Rosa Maria Lamuela-Raventós; Lluís Serra-Majem; Xavier Pintó; Valentina Ruiz-Gutiérrez; Josep Basora; Jordi Salas-Salvadó Journal: BMC Med Date: 2013-07-16 Impact factor: 8.775
Authors: Alexander Medina-Remón; Rosa Casas; Anna Tressserra-Rimbau; Emilio Ros; Miguel A Martínez-González; Montserrat Fitó; Dolores Corella; Jordi Salas-Salvadó; Rosa M Lamuela-Raventos; Ramón Estruch Journal: Br J Clin Pharmacol Date: 2016-05-19 Impact factor: 4.335
Authors: Heidi Taylor; Kirsten Webster; Andrew R Gray; Siew Ling Tey; Alex Chisholm; Karl Bailey; Shivani Kumari; Rachel C Brown Journal: Eur J Nutr Date: 2017-09-27 Impact factor: 5.614
Authors: Katherine R Pearson; Siew Ling Tey; Andrew R Gray; Alexandra Chisholm; Rachel C Brown Journal: Eur J Nutr Date: 2016-02-20 Impact factor: 5.614